Search research articles
Contact Us
Filters
Showing results (11-20 of 102) with videos related to
Page
of 11
Sort By:
Gastroenterology
|
December 17, 2016
Elucidating the Role of the Interleukin-10 Receptor in Mucosal Inflammation Uncovers a Potential Treatment for Infantile Inflammatory Bowel Disease
Phillip D Smith, Charles O Elson
International Immunopharmacology
|
November 30, 2010
Treg cell-IgA axis in maintenance of host immune homeostasis with microbiota
Ting Feng, Charles O Elson, Yingzi Cong
Gut Microbes
|
April 7, 2011
Microbiota: dual-faceted player in experimental colitis
Ting Feng, Charles O Elson, Yingzi Cong
Vaccine
|
March 1, 2005
Immune response versus mucosal tolerance to mucosally administered antigens
Jiri Mestecky, Zina Moldoveanu, Charles O Elson
Inflammatory Bowel Diseases
|
January 18, 2023
Epicutaneous Immunotherapy with CBir1 Alleviates Intestinal Inflammation
Xin Chen, Charles O Elson, David Dunkin
Journal of Immunology (Baltimore, Md. : 1950)
|
October 20, 2007
Perspectives on mucosal vaccines: is mucosal tolerance a barrier?
Jiri Mestecky, Michael W Russell, Charles O Elson
Advances in Experimental Medicine and Biology
|
April 20, 2006
Alterations of T lymphocytes in inflammatory bowel diseases
Charles O Elson, Yingzi Cong, Casey T Weaver
Plos One
|
July 28, 2017
CBirTox is a selective antigen-specific agonist of the Treg-IgA-microbiota homeostatic pathway
Katie L Alexander, Jannet Katz, Charles O Elson
Springer Seminars in Immunopathology
|
July 20, 2005
Animal models of intestinal inflammation: ineffective communication between coalition members
Robin G Lorenz, Vance J McCracken, Charles O Elson
Annals of the New York Academy of Sciences
|
February 1, 2005
Oral tolerance in humans: failure to suppress an existing immune response by oral antigen administration
Zina Moldoveanu, Fred Oliver, Jiri Mestecky, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 102) with videos related to
Sort By:
Page
of 11
Gastroenterology
|
December 17, 2016
Elucidating the Role of the Interleukin-10 Receptor in Mucosal Inflammation Uncovers a Potential Treatment for Infantile Inflammatory Bowel Disease
Phillip D Smith, Charles O Elson
International Immunopharmacology
|
November 30, 2010
Treg cell-IgA axis in maintenance of host immune homeostasis with microbiota
Ting Feng, Charles O Elson, Yingzi Cong
Gut Microbes
|
April 7, 2011
Microbiota: dual-faceted player in experimental colitis
Ting Feng, Charles O Elson, Yingzi Cong
Vaccine
|
March 1, 2005
Immune response versus mucosal tolerance to mucosally administered antigens
Jiri Mestecky, Zina Moldoveanu, Charles O Elson
Inflammatory Bowel Diseases
|
January 18, 2023
Epicutaneous Immunotherapy with CBir1 Alleviates Intestinal Inflammation
Xin Chen, Charles O Elson, David Dunkin
Journal of Immunology (Baltimore, Md. : 1950)
|
October 20, 2007
Perspectives on mucosal vaccines: is mucosal tolerance a barrier?
Jiri Mestecky, Michael W Russell, Charles O Elson
Advances in Experimental Medicine and Biology
|
April 20, 2006
Alterations of T lymphocytes in inflammatory bowel diseases
Charles O Elson, Yingzi Cong, Casey T Weaver
Plos One
|
July 28, 2017
CBirTox is a selective antigen-specific agonist of the Treg-IgA-microbiota homeostatic pathway
Katie L Alexander, Jannet Katz, Charles O Elson
Springer Seminars in Immunopathology
|
July 20, 2005
Animal models of intestinal inflammation: ineffective communication between coalition members
Robin G Lorenz, Vance J McCracken, Charles O Elson
Annals of the New York Academy of Sciences
|
February 1, 2005
Oral tolerance in humans: failure to suppress an existing immune response by oral antigen administration
Zina Moldoveanu, Fred Oliver, Jiri Mestecky, et al.
Page
of 11